Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Heart Failure Treatment and Management, Diabetes Treatment and Management, Cardiovascular Function and Risk Factors, and Cardiac Valve Diseases and Treatments.
Coordinated Expression of BMP10/ALK1/endoglin—Proteins that Drive Embryonic Cardiac and Vascular Morphogenesis—in Patients with Heart Failure: The EMPEROR Program
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations
Association of Electronic Cigarette Exposure on Cardiovascular Health: A Systematic Review and Meta-Analysis
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories
Health Status Across Major Subgroups of Patients with Heart Failure and Preserved Ejection Fraction
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction
Early benefit with empagliflozin in heart failure with preserved ejection fraction: <scp>insights from the EMPEROR‐Preserved trial</scp>
Outcomes with empagliflozin in heart failure with preserved ejection fraction using <scp>DELIVER</scp> ‐like endpoint definitions
Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the <scp>DIAMOND</scp> trial
Is there a smoker’s paradox in COVID-19?